Search

University of Texas Results of a recent study at the University of Texas Southwestern Medical Center (UT Southwestern) at Dallas indicate that a large percentage of people with AIDS may [...]

AUTHORS: K.M. Jackson, A.S. Sievers, B.C. Ross and B.W. Dwyer. Fairfield Hospital, Victoria, Australia. According to an abstract submitted by the authors to the general meeting of the American Society [...]

AUTHORS: M.B. Coyle, L.C. Carlson, C.K. Wallis, R.B. Leonard and V. Raisys. Harborview Medical Center and University of Washington, Seattle, Washington. According to an abstract submitted by the authors to [...]

AUTHORS: M. Yakrus, W. Butler, J. Kilburn, B. Plikaytis, C. Moss, V. Silcox, M. Floyd, F. Vadney and W. Gross. Centers for Disease Control, Atlanta, Georgia, and Department of Veterans [...]

SOURCE: The Journal of Infectious Diseases, May 1992;165(5):960-963. The outcome of cryptococcal meningitis for AIDS patients may actually be better than that for patients with neoplastic disease, a comparative study [...]

SOURCE: Chest, February 1992;101(2):581-582. Thirty healthcare workers tested positive for tuberculosis after exposure to an AIDS patient whose TB diagnosis was delayed. J.R. Pierce and colleagues of Texas Technical University [...]

Moffitt Cancer Center As antiviral therapy prolongs the lives of AIDS patients, physicians are beginning to see more lung and breast cancers not normally associated with these typically younger patients, [...]

SOURCE: Journal of Acquired Immune Deficiency Syndromes, February 1992;5(2):137-142. Oral pyrimethamine by itself can be an effective maintenance therapy for central nervous system (CNS) toxoplasmosis in AIDS patients, a retrospective [...]

SOURCE: American Journal of Ophthalmology, January 15, 1992;113(1):8-13. Even in the absence of retinitis, people with AIDS have a functional visual deficit, vision studies show. University of California, San Diego, [...]

SOURCE: The Journal of the American Medical Association, January 22/29, 1992;267(4):509-510. A regimen of low-dose chemotherapy and zidovudine (AZT) are not effective in the treatment of poor-prognosis AIDS-associated non-Hodgkins lymphoma [...]

SOURCE: Archives of Dermatology, November 1991;127(11):1699-1701. Clinicians should be aware that extrapulmonary Pneumocystis carinii may present as an apparently innocuous skin eruption in AIDS patients. University of Texas Southwest Medical [...]

AUTHORS: C.D. Berry, M.J. Blaser, M.A. Johnson, M.T. Levin, P. Echeverria and R.T. Ellison III. DVAMC and University of Colorado, Denver, Colorado; AFRIMS, Bangkok, Thailand; Vanderbilt University, Nashville, Tennessee. According [...]

AUTHORS: G. Sanchez, S. Ponce de Leon and G. Ruiz-Palacios. Instituto Nacional de la Nutrition, Mexico. According to an abstract submitted by the authors to the 31st Interscience Conference on [...]

American Society of Hematology Clinical results presented at the Annual Meeting of the American Society of Hematology held in Denver, Colorado, indicate that the drug Daunoxome may have significant capability [...]

SOURCE: Annals of Internal Medicine, November 15, 1991;115(10):760-763. Long-term maintenance therapy for toxoplasmosis protects AIDS patients from Pneumocystis carinii pneumonia (PCP), a Swiss study indicates. University of Geneva researchers A. [...]

SOURCE: The Lancet, November 2, 1991;338(8775):1107-1109. The semi-synthetic macrolide antibiotic azithromycin is a safe and apparently effective treatment for Mycobacterium avium complex disease, an uncontrolled Phase 1 study indicates. Medical [...]

AUTHORS: T. Saint-Marc and J.L Touraine. Hopital Edouard Herriot, Lyon, France. According to an abstract submitted by the authors to the 31st Interscience Conference on Antimicrobial Agents and Chemotherapy, held [...]

AUTHORS: L.S. Young, L. Wiviott, M. Wu, P. Kolonoski, C.B. Inderlied and R. Bolan. Kuzell Institute and Pacific Presbyterian Medical Center, San Francisco, California; Children's Hospital, Los Angeles, California. According [...]

AUTHORS: U. de Girolami, T. W. Smith, D. Henin, J-J. Hauw. New England Deaconess Hospital, Boston, Massachusetts; University of Massachusetts, Worcester, Massachusetts; Hopital de La Salpetriere, Paris, France According to [...]

AUTHORS: M. A. Jacobson, M. Wulfsohn, J. Feinberg, R. Davis, M. Power and C.S. Crumpacker. San Francisco General Hospital and University of California, San Francisco; Harvard School of Public Health [...]

SOURCE: American Journal of Psychiatry, November 1991;148(11):1558-1561. AIDS patients treated with dopamine-blocking agents for psychosis develop parkinsonian complications 2.4 times more frequently than non-AIDS patients, a preliminary study indicates. E. [...]

Treatment of AIDS Dementia, Myelopathy and Blindness Assignee: Children's Medical Center Corp. Patent No.: 5,043,419 Inventors: Lipton, S.A. Abstract: A method of reducing death of CNS neurons in a human [...]

AUTHORS: G. Walckenaer, C. Leport, P. Longuet, G. Raguin, C. Perronne and J.L. Vilde. Hopital Claude Bernard, University Paris VII, France. According to an abstract submitted by the authors to [...]

AUTHORS: M.S. Saag, W.G. Powderly, R. Hamill, J.R. Gray-Bill, H.A. Waskin, R. Hafner, J. Albrecht and W.E. Dismukes. NIAID Mycoses Study Group and AIDS Clinical Trials Group, Birmingham, Alabama; St. [...]

VII International Conference on AIDS Fluconazole demonstrated superior efficacy to ketoconazole in the first large prospective clinical study of the response of Candida esophagitis to antifungal therapy. The study was [...]

VII International Conference on AIDS Fluconazole at high doses is well-tolerated and effective as therapy for AIDS*related cryptococcal meningitis that is refractory to other antifungal regimens, according to the results [...]

The Netherlands Fluconazole has become the agent of choice for both oral and esophageal candidiasis in patients with AIDS, according to a presentation made at Opportunistic Infections: Pathogenesis and Therapy, [...]

Johns Hopkins School of Public Health Johns Hopkins School of Public Health researchers have shown that early use of zidovudine (AZT) and preventive drugs for an AIDS-related pneumonia called PCP [...]

U.S. FDA The U.S. Food and Drug Administration (FDA) said its advisory committee recommended the approval of a drug made by Swedish firm Astra A.B. which appears to control an [...]

VII International Conference on AIDS TLC G-65, a liposomal form of the antibiotic gentamicin, showed activity against Mycobacterium avium -intracellulare (MAI), an infection in AIDS patients, in a Phase I/II [...]

SOURCE: The American Journal of Medicine, April 1991;90(4):427-433. Low-dose combination chemotherapy for extensive AIDS -associated Kaposi's sarcoma (KS) with Adriamycin (doxorubicin), bleomycin, and vincristine (ABV therapy) yields a higher response [...]

VII International Conference on AIDS AIDS-infected patients suffering from hepatitis C may benefit from treatment with AZT, an AIDS drug previously denied to them. A study presented at the VII [...]

AUTHORS: J. Falloon, D. O'Neill, S. LaFon, M. Rogers, C. Tuazon, I. Feuerstein, and H. Masur. National Institutes of Health, Bethesda, Md.; and Burroughs-Wellcome Co., Research Triangle Park, N.C. According [...]

AUTHORS: G. Ramirez, D. Way, M. Witte, M. Bernas, R. Nagle, M. Fiala, C. Witte and M. Milligan. Departments of Surgery and Pathology, University of Arizona College of Medicine, Tucson, [...]

AUTHORS: R.C. Stevens, S.C. Laizure, D.S. Stein and C.L. Holden. Departments of Clinical Pharmacy and Medicine, University of Tennessee, Memphis. According to the abstract of the authors' poster presentation at [...]

U.S. FDA Abbott Laboratories announced that it has contacted the U.S. Food and Drug Administration (FDA) to propose a draft protocol for compassionate use of the new antibiotic, clarithromycin, in [...]

Belmac Corporation Belmac Corporation, Tampa, Florida, announced that it has acquired licensing rights to the antibiotic, gangamicin, recently developed at the National Jewish Center for Immunology and Respiratory Medicine in [...]

DATELINE: Stanford University Medical Center Pulmonary aspergillosis, a lung disease, is starting to affect AIDS patients who have survived other infections, according to a report in the New England Journal [...]

AUTHORS: K. Miller, T. Nadasdy, L. Davis, O. Hanson-Painton, L. DeBault, D. Burns, E. Hawkins and F. Silva. University of Oklahoma, Oklahoma City; University of Texas, Dallas; and Baylor College [...]

AUTHORS: V. Pardo, G. Howard, M. Bell, A.C. Longone, I. Hernandez and J. Strauss. Departments of Pathology and Pediatrics, University of Miami, Fla.; Broward Medical Examiner; and Research Service VAMC. [...]

AUTHORS: B. Herndier1, B. Shiramizu1, C. Clark1, T. Meeker2, L. Kaplan1, and M. McGrath1. 1University of California, San Francisco, and 2Veterans Administration Medical Center, San Francisco. According to the abstract [...]

DATELINE: AIDS Television Network A demonstration of the use of liquid nitrogen for the treatment of early patches and plaques of Kaposi's sarcoma lesions will be featured on the April [...]

DATELINE: Focus on Fungal Infections Conference Despite improving treatments against cryptococcal meningitis, one-fifth of all patients with AIDS who contract the fungal infection eventually die from it, according to a [...]

AUTHORS: M.M. Bacchi, W.S. Nichols, D. Hanke, D. Rascon and P. Kidd. University of Washington, Seattle; and Cedars Sinai Medical Center, Los Angeles. According to the abstract of the authors' [...]

Treatment of the acquired immune deficiency syndrome-related Kaposi's sarcoma with bleomycin as a single agent. Researchers from the Hospital Saint-Louis in Paris and their colleagues found that bleomycin, an antimitotic [...]

Low-dose dapsone prophylaxis of Pneumocystis carinii pneumonia in AIDS and AIDS-related complex. Researchers from the Santa Clara Valley (CA) Medical Center found that the use of oral dapsone as a [...]

The Liposome Company, Inc. announced that it has filed with the United States Securities and Exchange Commission a registration statement covering a proposed offering of 3 million shares of common [...]

San Francisco According to the San Francisco (California) Department of Public Health AIDS Office, a recent linkage of datasets from the San Francisco AIDS Registry and the California Tumor Registry [...]

AUTHORS: G. Ramirez, D. Way, M. Witte, M. Bernas, R. Nagle, M. Fiala, C. Witte and M. Milligan. Departments of Surgery and Pathology, University of Arizona College of Medicine, Tucson, [...]

SOURCE: Current Therapeutic Research, December 1990; 48(6):974-979. Combination therapy with thymostimulin (Tp1) and erythromycin outperformed erythromycin alone in the treatment of acute Cryptosporidium enteritis, a small Italian clinical trial indicates. [...]